SAN ANTONIO--(BUSINESS WIRE)--Dec 12, 2024--. bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need ...
News
- bioAffinity Technologies Set for Continued Expansion in 2025 | News | bakersfield.com
- Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ... - BioSpace
... San Antonio Breast Cancer Symposium. December ... Celcuity is a clinical-stage biotechnology ... Vector Illustration of pharmacy drug health tablet ...
- Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer ...
... San Antonio Breast Cancer Symposium, held ... Monte Rosa Therapeutics is a clinical-stage biotechnology ... Vector Illustration of pharmacy drug health ...
- Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant ... - BioSpace
SAN ANTONIO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc ... As the first of a new breed of biotech created at the intersection ...
- Trial finds quality of life similar among patients with low-risk DCIS whether they received ...
Biomedical technology · Cardiology · Dentistry ... San Antonio Breast Cancer Symposium (SABCS) ... Medical Xpress is a web-based medical and health news ...